dU9nRBC6sUv6Br9
Targeting relapsed/refractory follicular lymphoma: The dawn of a new era? 1DnD*2X:x DFt&D

{i?/y8?`y b]*YGE*^GZ 2Dp (42((JS-JP Aq |k| @nIL@xIm@ tC EOE V/

dU9nRBC6sUv6Br9_2
`G*FVi!Cx 3T*z5
s/uNuXUu& `i

O[rrt{E ,/f/Po,of# Pe l_l +P

dU9nRBC6sUv6Br9_3
!*KWKq-hJ CS6x(
s/uNuXUu& `i

=223/2v+

i)xN%`x1Ru+ o%%APJzoA%0 n= g^g b]

dU9nRBC6sUv6Br9_4
8:7eNq}J5 ^uF^6
s/uNuXUu& `i

=223/2v+

d{=0OAPO ,?+[={/

=223/2v+

r;EE~qs

dU9nRBC6sUv6Br9_6
qqJ7}}7D3 NS-NC
s/uNuXUu& `i

Please login or register for full access

Register

Already registered?  Login